Patents by Inventor Delphine Benarroch

Delphine Benarroch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Active truncated form of the RNA polymerase of
    Patent number: 8030047
    Abstract: The isolation and purification of two domains from a from a flavivirus is provided. Each domain can function independently. Moreover, one domain codes for a sequence that provide polymerase activity. A process for screening possible modulators of the polymerase activity of an isolated and purified polypeptide from flavivirus is also disclosed.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: October 4, 2011
    Assignee: Centre National de la Recherche Scientifique-CNRS
    Inventors: Jean-Louis Romette, Bruno Canard, Marie-Pierre Egloff, Barbara Selisko, Delphine Benarroch
  • ACTIVE TRUNCATED FORM OF THE RNA POLYMERASE OF FLAVIVIRUS
    Publication number: 20100267113
    Abstract: The isolation and purification of two domains from a from a flavivirus is provided. Each domain can function independently. Moreover, one domain codes for a sequence that provide polymerase activity. A process for screening possible modulators of the polymerase activity of an isolated and purified polypeptide from flavivirus is also disclosed.
    Type: Application
    Filed: October 22, 2008
    Publication date: October 21, 2010
    Applicant: CENTRE NAT DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Jean-Louis ROMETTE, Bruno Canard, Marie-Pierre Egloff, Barbara Selisko, Delphine Benarroch
  • ACTIVE TRUNCATED FORM OF THE RNA POLYMERASE OF FLAVIVIRUS
    Publication number: 20090221795
    Abstract: The isolation and purification of two domains from a from a flavivirus is provided. Each domain can function independently. Moreover, one domain codes for a sequence that provide polymerase activity. A process for screening possible modulators of the polymerase activity of an isolated and purified polypeptide from flavivirus is also disclosed.
    Type: Application
    Filed: October 22, 2008
    Publication date: September 3, 2009
    Applicant: CENTRE NAT DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Jean-Louis Romette, Bruno Canard, Marie-Pierre Egloff, Barbara Selisko, Delphine Benarroch
  • Active truncated form of the RNA polymerase of flavivirus
    Patent number: 7459297
    Abstract: The isolation and purification of two domains from a from a flavivirus is provided. Each domain can function independently. Moreover, one domain codes for a sequence that provide polymerase activity. A process for screening possible modulators of the polymerase activity of an isolated and purified polypeptide from flavivirus is also disclosed.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: December 2, 2008
    Assignee: Centre National de la Recherche Scientifique -CNRS
    Inventors: Jean-Louis Romette, Bruno Canard, Marie-Pierre Egloff, Barbara Selisko, Delphine Benarroch
  • Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
    Patent number: 6949353
    Abstract: This invention concerns an isolated and purified polypeptide capable of acting as a guanylyltransferase and methyltransferase comprising capping enzyme of flavivirus (CEF). The invention also concerns the use of such polypeptide to identify biologically active molecule wich can be used in the treatment or the prevention of diseases resulting from Flavivirus infection.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: September 27, 2005
    Assignee: Centre National de la Recherche Scientifique, C.N.R.S.
    Inventors: Jean-Louis Romette, Delphine Benarroch, Bruno Canard, Marie-Pierre Egloff
  • CAPPING ENZYME OF FLAVIVIRUS AND UTILIZATION OF THIS PROTEIN IN A PROCESS TO TEST DRUGS WITH ANTIVIRAL PROPERTIES
    Publication number: 20050100882
    Abstract: This invention concerns an isolated and purified polypeptide capable of acting as a guanylyltransferase and methyltransferase comprising capping enzyme of flavivirus (CEF). The invention also concerns the use of such polypeptide to identify biologically active molecule wich can be used in the treatment or the prevention of diseases resulting from Flavivirus infection.
    Type: Application
    Filed: May 31, 2002
    Publication date: May 12, 2005
    Inventors: Jean-Louis Romette, Delphine Benarroch, Bruno Canard, Marie-Pierre Egloff
  • Active truncated form of the RNA polymerase of flavivirus
    Publication number: 20050048472
    Abstract: The isolation and purification of two domains from a from a flavivirus is provided. Each domain can function independently. Moreover, one domain codes for a sequence that provide polymerase activity. A process for screening possible modulators of the polymerase activity of an isolated and purified polypeptide from flavivirus is also disclosed.
    Type: Application
    Filed: May 28, 2004
    Publication date: March 3, 2005
    Inventors: Jean-Louis Romette, Bruno Canard, Marie-Pierre Egloff, Barbara Selisko, Delphine Benarroch